Integrative biological studies of antitumour agents

Integrative biological studies of antitumour agents

Dettagli Bibliografici
Autori principali:	Johnson, L, Willis, A, Byrne, H, Laughton, C
Natura:	Conference item
Pubblicazione:	2008

Documenti analoghi

An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4.
di: Johnson, L, et al.
Pubblicazione: (2011)

A systems biology approach to the analysis of DNA-interactive antitumour agents
di: Laughton, C, et al.
Pubblicazione: (2006)

The Chemistry of antitumour agents /
di: Wilman, Derry E. V.
Pubblicazione: (1990)

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
di: Magda A.-A. El-Sayed, et al.
Pubblicazione: (2018-01-01)

An approach to the generation of simple analogues of the antitumour agent spicamycin.
di: Mons, S, et al.
Pubblicazione: (2003)

Synthesis of quinazolindionyl amino acid and dipeptide derivatives as possible antitumour agents
di: A. Aboelmagd, et al.
Pubblicazione: (2019-07-01)

A highly cytotoxic L-rhamnose analogue of the antitumour agent spicamycin
di: Martin, A, et al.
Pubblicazione: (1998)

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland
di: D Kyburz, et al.
Pubblicazione: (2020-02-01)

Synthesis and biological evaluation of enantiomeric rhamnose analogues of the antitumour agent spicamycin - is the mode of action by modification of N-linked glycoproteins?
di: Martin, A, et al.
Pubblicazione: (1999)

Antitumour-promoting and antitumour activities of the crude extract from the leaves of Juniperus chinensis
di: Ali, Abdul Manaf, et al.
Pubblicazione: (1996)

Biochemical mechanisms of platinum antitumour drugs /
di: McBrien, D. C. H., et al.
Pubblicazione: (1986)

On the antitumour effects of B vitamins
di: O. A. Gromova, et al.
Pubblicazione: (2024-02-01)

An Overview of Antitumour Activity of Polysaccharides
di: Hongzhen Jin, et al.
Pubblicazione: (2022-11-01)

TIN-BASED ANTITUMOUR DRUGS
di: Gielen, Marcel
Pubblicazione: (1994-05-01)

Novel disulfides with antitumour efficacy and specificity
di: Griffiths, R, et al.
Pubblicazione: (2005)

Antitumour principles from alpinia galanga /
di: Hideji Itokawa

Antitumour Effects of Astaxanthin and Adonixanthin on Glioblastoma
di: Shohei Tsuji, et al.
Pubblicazione: (2020-09-01)

R(h)oad to antitumour therapy
di: Viviane Nascimento Da Conceicao, et al.
Pubblicazione: (2022-12-01)

Adsorption of Some Antitumour Compounds on Polymer Adsorbents
di: M.O. Kovbuz, et al.
Pubblicazione: (1996-08-01)

Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
di: Liu J, et al.
Pubblicazione: (2020-01-01)

Semisynthesis of Andrographolide Derivatives and Evaluation of Their Antitumour Properties
di: Rao, Jada Srinivasa
Pubblicazione: (2004)

The Antitumour Mechanisms of Carotenoids: A Comprehensive Review
di: Andrés Baeza-Morales, et al.
Pubblicazione: (2024-08-01)

Synthesis and antitumour activity of varitriol and its analogues
di: Oľga Caletková, et al.
Pubblicazione: (2012-05-01)

Recent Advances in Functional Carbon Quantum Dots for Antitumour
di: Cai R, et al.
Pubblicazione: (2021-10-01)

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
di: Katrin Kramer, et al.
Pubblicazione: (2019-01-01)

Antitumour Activity of Dehydroxymethylepoxyquinomycin (DHMEQ): a Literature Review
di: K. Umezawa, et al.
Pubblicazione: (2021-04-01)

A single‐domain small protein Med‐ORF10 regulates the production of antitumour agent medermycin in Streptomyces
di: Xiaofeng Cai, et al.
Pubblicazione: (2021-09-01)

Impact of oncogenic pathways on evasion of antitumour immune responses
di: Spranger, Stefani
Pubblicazione: (2020)

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma
di: Rahel Mascha Stammer, et al.
Pubblicazione: (2017-01-01)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
di: Emily J. Kay, et al.
Pubblicazione: (2023-04-01)

Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics
di: Piao Zhou, et al.
Pubblicazione: (2021-01-01)

Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment
di: Moises A. Franco-Molina, et al.
Pubblicazione: (2018-07-01)

Evaluation of the purified fraction of Wilbrandia (c. f. ) verticillata for antitumour activity
di: V. S. N. Rao, et al.
Pubblicazione: (1991-01-01)

Phenolic profile, antibacterial, antimutagenic and antitumour evaluation of Veronica urticifolia Jacq.
di: Jelena Živković, et al.
Pubblicazione: (2014-07-01)

Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.
di: Fens, M, et al.
Pubblicazione: (2008)

Boosting antitumour immunity through targeted delivery of interferon-α
di: Fairchild, P, et al.
Pubblicazione: (2019)

Advances in antitumour therapy with oncolytic herpes simplex virus combinations
di: Xuejiao Qi
Pubblicazione: (2024-07-01)

Learning the Lessons of Antitumour Necrosis Factor Therapy-Associated Psoriasis
di: Matt Shale, et al.
Pubblicazione: (2009-01-01)

Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity
di: Shlomo Ben-Efraim
Pubblicazione: (1992-01-01)

Design, synthesis and antitumour activity evaluation of novel dolutegravir derivatives
di: Xi-Xi Hou, et al.
Pubblicazione: (2023-08-01)